Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2205 | 4410 | 47.6 | 92% |
Classes in level above (level 3) |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
4925 | 1632 | MYC//MAX//C MYC |
9172 | 1112 | POU DOMAIN//BRN 3A//BRN 3 |
13082 | 797 | ID 1//ID4//ID2 |
18839 | 468 | NRSF//NRSF REST//REST NRSF |
27490 | 187 | USF1//UPSTREAM TRANSCRIPTION FACTOR 1//USF |
29744 | 148 | DEC1//DEC2//STRA13 |
34664 | 66 | BLAST SEARCH//GENES FOR BASIC HELIX LOOP HELIX PROTEINS//ORTHOLOGOUS FAMILY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ID 1 | Author keyword | 97 | 60% | 2% | 107 |
2 | NRSF | Author keyword | 76 | 86% | 1% | 38 |
3 | MYC | Author keyword | 74 | 25% | 6% | 254 |
4 | POU DOMAIN | Author keyword | 55 | 58% | 1% | 62 |
5 | BRN 3A | Author keyword | 50 | 88% | 1% | 23 |
6 | MAX | Author keyword | 47 | 46% | 2% | 76 |
7 | NRSF REST | Author keyword | 34 | 93% | 0% | 13 |
8 | C MYC | Author keyword | 33 | 11% | 6% | 270 |
9 | ID4 | Author keyword | 31 | 73% | 1% | 24 |
10 | ID2 | Author keyword | 27 | 46% | 1% | 44 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ID 1 | 97 | 60% | 2% | 107 | Search ID+1 | Search ID+1 |
2 | NRSF | 76 | 86% | 1% | 38 | Search NRSF | Search NRSF |
3 | MYC | 74 | 25% | 6% | 254 | Search MYC | Search MYC |
4 | POU DOMAIN | 55 | 58% | 1% | 62 | Search POU+DOMAIN | Search POU+DOMAIN |
5 | BRN 3A | 50 | 88% | 1% | 23 | Search BRN+3A | Search BRN+3A |
6 | MAX | 47 | 46% | 2% | 76 | Search MAX | Search MAX |
7 | NRSF REST | 34 | 93% | 0% | 13 | Search NRSF+REST | Search NRSF+REST |
8 | C MYC | 33 | 11% | 6% | 270 | Search C+MYC | Search C+MYC |
9 | ID4 | 31 | 73% | 1% | 24 | Search ID4 | Search ID4 |
10 | ID2 | 27 | 46% | 1% | 44 | Search ID2 | Search ID2 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RAS COTRANSFORMATION | 144 | 94% | 1% | 50 |
2 | RESTRICTIVE SILENCER FACTOR | 106 | 53% | 3% | 141 |
3 | MYC MAX MAD NETWORK | 86 | 72% | 2% | 68 |
4 | ID 1 | 83 | 63% | 2% | 83 |
5 | MAX | 82 | 36% | 4% | 185 |
6 | LOOP HELIX PROTEINS | 72 | 22% | 7% | 295 |
7 | CELL SPECIFIC COACTIVATOR | 61 | 78% | 1% | 40 |
8 | ID 1 PROTEIN | 59 | 90% | 1% | 26 |
9 | NEURONAL GENES | 59 | 59% | 1% | 66 |
10 | STRA13 | 46 | 78% | 1% | 31 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
MYC on the Path to Cancer | 2012 | 344 | 214 | 49% |
RE-1 silencing transcription factor (REST): a regulator of neuronal development and neuronal/endocrine function | 2015 | 4 | 66 | 73% |
Myc and cell cycle control | 2015 | 6 | 215 | 47% |
Transcriptional regulation and transformation by MYC proteins | 2005 | 563 | 146 | 61% |
MYC - TIMELINE Reflecting on 25 years with MYC | 2008 | 450 | 281 | 50% |
Myc's broad reach | 2008 | 358 | 129 | 61% |
The c-Myc target gene network | 2006 | 370 | 127 | 64% |
Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis | 2015 | 4 | 257 | 55% |
MYC as a regulator of ribosome biogenesis and protein synthesis | 2010 | 165 | 120 | 44% |
c-myc target genes involved in cell growth, apoptosis, and metabolism | 1999 | 861 | 193 | 62% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DENT MED BIOCHEM | 8 | 28% | 0.5% | 24 |
2 | MED MOL BIOL UNIT | 5 | 14% | 0.7% | 31 |
3 | MOLEK BIOL TUMORFOR | 4 | 50% | 0.1% | 6 |
4 | CELL INTEGRAT BIOL | 3 | 100% | 0.1% | 3 |
5 | EDWARD MALLINCKRODT PEDIAT MOL BIOL PHAR | 3 | 100% | 0.1% | 3 |
6 | TR ON | 3 | 100% | 0.1% | 3 |
7 | CANC THER EUT DEV | 3 | 20% | 0.3% | 14 |
8 | MED MOLEC PATHOL MED MOLEC BIOL UNIT | 3 | 31% | 0.2% | 8 |
9 | MED MOLEC PATHOL | 3 | 25% | 0.2% | 10 |
10 | SHANDONG PROV TUMOR TARGET MOL | 3 | 60% | 0.1% | 3 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000017912 | CHRONIC MYELOID LEUKEMIA//IMATINIB//BCR ABL |
2 | 0.0000012827 | BRANCHIO OCULO FACIAL SYNDROME//RIZ1//BCL6 |
3 | 0.0000012538 | ETS 1//PU1//HEMANGIOBLAST |
4 | 0.0000011144 | CELL CYCLE//CDK5//E2F |
5 | 0.0000010325 | SERUM RESPONSE FACTOR//MYOCARDIN//KLF4 |
6 | 0.0000009916 | ASTROCYTE ELEVATED GENE 1//AEG 1//DREF |
7 | 0.0000009532 | E1A//BIOL MOL ELADIO VINUELA//PHAGE PHI 29 |
8 | 0.0000009183 | EGR 1//C FOS//CREM |
9 | 0.0000008946 | EPITHELIAL MESENCHYMAL TRANSITION//EMT//SNAIL |
10 | 0.0000008508 | CHROMATIN//EZH2//NUCLEOSOME |